Statistics

Total Visits

Views
Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study105

Select a period of time:

Number of views in the range

Views
Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study20

Views

Views
October 20253
November 20255
December 20253
January 20262
February 20260
March 20263
April 20264
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil6
United States4
Argentina2
Bolivia1
Colombia1
Germany1
Egypt1
Finland1
Mexico1
El Salvador1
 

Top cities views

Views
Ashburn2
Americana1
Cairo1
Caxias do Sul1
Chesapeake1
Ciudadela1
Estância Velha1
Frankfurt am Main1
Helsinki1
La Paz1